DoD Lung Cancer Clinical Exploration Award
The summary for the DoD Lung Cancer Clinical Exploration Award grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the Dept of the Army USAMRAA, which is the U.S. government agency offering this grant.
DoD Lung Cancer Clinical Exploration Award: The LCRP Clinical Exploration Award mechanism is being offered for the first time in FY13. The intent of the LCRP Clinical Exploration Award (CEA) is to support early-phase, proof-of-principle clinical trials and correlative studies to investigate hypothesis-based, innovative interventions and/or avenues of research that have the potential to resolve current clinical barriers and result in a profound impact on the clinical management of lung cancer. While therapeutic approaches proposed for testing through the CEA must represent novel, hypothesisbased, "outside-the-box" approaches for treating lung cancer, they may include therapies already in clinical use, or undergoing clinical testing, for other diseases, provided that the proposed use for lung cancer would lead to a major advancement for treating the disease. It is anticipated that outcomes from studies funded by this award will provide scientific rationale for subsequent development of larger, efficacy-based clinical trials of interventions that will transform lung cancer clinical care. Submissions from and partnerships with investigators at Military Medical Treatment Facilities, Military labs, and the Department of Veterans Affairs (VA) Medical Centers and research laboratories are encouraged. Clinical Trials: The CEA will support clinical trials encompassing Phase 0, Phase I, or pilot Phase II for drug or drug combinations, Class II or III devices, or other types of trials that conduct early clinical testing of innovative approaches for lung cancer.
Federal Grant Title: | DoD Lung Cancer Clinical Exploration Award |
Federal Agency Name: | Dept of the Army USAMRAA |
Grant Categories: | Science and Technology |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | W81XWH-13-LCRP-CEA |
Type of Funding: | Cooperative Agreement Grant |
CFDA Numbers: | 12.420 |
CFDA Descriptions: | Military Medical Research and Development |
Current Application Deadline: | Oct 16, 2013 |
Original Application Deadline: | Oct 16, 2013 |
Posted Date: | May 21, 2013 |
Creation Date: | May 21, 2013 |
Archive Date: | Nov 15, 2013 |
Total Program Funding: | $720,000 |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | 1 |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
- Grant Announcement Contact
- CDMRP Help Desk 301-682-5507
CDMRP Help Desk [[email protected]] - Similar Government Grants
- • DoD Tick-Borne Disease, Idea Development Award
- • DoD Tick-Borne Disease, Therapeutic/Diagnostic Research Award
- • DoD Rare Cancers, Concept Award
- • DoD Multiple Sclerosis, Early Investigator Research Award
- • DoD Rare Cancers, Idea Development Award
- • FY2006 Deployed War Fighter Protection Research Program
- • Department of Defense (DOD) Fiscal Year 2003 (FY03) Breast Cancer Research Program (BCRP)C...
- • Department of Defense (DOD) Fiscal Year 2004 (FY04) Breast Cancer Research Program (BCRP) ...
- More Grants from the Dept of the Army USAMRAA
- • DoD Tick-Borne Disease, Idea Development Award
- • DoD Tick-Borne Disease, Therapeutic/Diagnostic Research Award
- • DoD Rare Cancers, Concept Award